AzTrials
AzTrials

Research institution

University of Florida Clinical Trials

Studies where University of Florida is the lead sponsor: what is enrolling now, by phase, condition and country.

1,285 registered studies

In numbers

Open to volunteers
198
Active
253
With results posted
331
All registered
1,285

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 198
  • Endometrioid Endometrial Adenocarcinoma

    A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

    • Recruiting
    • Age: 18 years and older
    • Phase 2
    • Pill or oral medicine
    • Injection or infusion

    This study will explore the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) used concurrently with levonorgestrel intrauterine device in patients with poor surgical candidacy for a hysterectomy or patients who are…

    Trial name
    NCT07107334
    Testing
    Glucagon-like peptide 1 receptor agonist
    Where
    United States
    Volunteers
    20 people
    Sponsor
    University of Florida
    Can I take part? NCT07107334
  • Emotional Regulation, Alcohol Drinking in College

    Momentary Coping Prompts and Hair Steroids in College Students

    • Recruiting
    • Age: 18 to 22 years
    • Lifestyle or therapy programme

    This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcohol, and eating in response to emotions.

    Conditions
    Emotional Regulation, Alcohol Drinking in College, Emotional Eating, Aggression
    Trial name
    REACT-Bio (NCT07782398)
    Testing
    Momentary coping prompt, Active control message
    Where
    United States
    Volunteers
    80 people, healthy volunteers welcome
    Sponsor
    University of Florida
    Can I take part? REACT-Bio
  • Emotional Regulation, Alcohol Drinking in College

    Just-in-Time Coping Prompts for Reactive Digital Behavior in College Students

    • Recruiting
    • Age: 18 to 22 years
    • Lifestyle or therapy programme

    This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcohol, and eating in response to emotions.

    Conditions
    Emotional Regulation, Alcohol Drinking in College, Emotional Eating, Aggression
    Trial name
    REACT (NCT07789314)
    Testing
    Momentary coping prompt, Active control message
    Where
    United States
    Volunteers
    80 people, healthy volunteers welcome
    Sponsor
    University of Florida
    Can I take part? REACT
  • Brain Metastases

    IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases

    • Recruiting
    • Age: 18 to 80 years
    • Phase 1
    • Injection or infusion
    • Medical device

    This is a Phase I Study evaluating the safety and feasibility of IL-8 receptor-modified patient-derived activated CD70 CAR T cells in adult patients with brain metastases from primary cancer, with either newly diagnosed lesions…

    Trial name
    IMPACT MET (NCT07569263)
    Testing
    Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells, CD70 IHC assay
    Where
    United States
    Volunteers
    12 people
    Sponsor
    University of Florida
    Can I take part? IMPACT MET
  • Pancreatic Ductal Adenocarcinoma

    Repurposing Mefloquine for Pancreatic Cancer Treatment

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 1
    • Pill or oral medicine

    Pancreatic cancer (specifically pancreatic ductal adenocarcinoma, PDAC) is a very aggressive disease that is often diagnosed too late for surgery, and the medicines currently available, mainly two chemotherapy combinations called…

    Trial name
    NCT07875907
    Testing
    Mefloquine, Modified FOLFIRINOX, gemcitabine and nab paclitaxel
    Volunteers
    36 people
    Sponsor
    University of Florida
    Can I take part? NCT07875907
  • Hypertension, Resistant to Conventional Therapy

    Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

    • Recruiting
    • Age: 18 to 100 years
    • Phase 4

    The goal of this clinical trial is to learn about the mechanisms by which minocycline effect blood pressure in individuals with treatment-resistant hypertension.

    Trial name
    NCT06246396
    Testing
    Minocycline Hydrochloride
    Where
    United States
    Volunteers
    120 people
    Sponsor
    University of Florida
    Can I take part? NCT06246396
  • Solid Tumor, Adult

    Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 2
    • Pill or oral medicine

    Public awareness of ivermectin's purported anticancer properties has led to widespread off-label use. In a 2023 cross-sectional study in Loja, Ecuador, 19% of respondents reported using ivermectin as an adjunct to cancer…

    Trial name
    ICONIC (NCT07487805)
    Testing
    Intermediate-dose ivermectin, High-dose ivermectin
    Volunteers
    80 people
    Sponsor
    University of Florida
    Can I take part? ICONIC
  • Vulvodynia

    A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia

    • Not yet recruiting
    • Age: 18 to 99 years
    • Phase 2
    • Pill or oral medicine

    The goal of this observational pilot study is to assess the safety, efficacy, and tolerability of oral low dose naltrexone (LDN) in the treatment of vulvodynia.

    Trial name
    NCT07862400
    Testing
    Low Dose Naltrexone
    Where
    2 sites in United States
    Volunteers
    20 people
    Sponsor
    University of Florida
  • Papillomavirus Vaccines

    ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

    • Recruiting
    • Age: 8 to 99 years
    • Vaccines
    • Lifestyle or therapy programme

    There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with…

    Trial name
    NCT06535139
    Testing
    Brief training, Parent-targeted motivational aids, Healthcare access
    Where
    United States
    Volunteers
    4,630 people
    Sponsor
    University of Florida
  • Duchenne Muscular Dystrophy, Duchenne Disease

    Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients

    • Recruiting
    • Age: 6 years and older
    • Phase 2
    • Pill or oral medicine

    This pilot study will investigate the potential efficacy of VM100, a nutritional supplement specifically formulated for patients with DMD, on quality of life and physical symptoms.

    Conditions
    Duchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy in Children, DMD
    Trial name
    NCT07766980
    Testing
    VM100 Nutritional Supplement
    Where
    United States
    Volunteers
    20 people
    Sponsor
    University of Florida

Completed, with results posted

All –
  • Cognitive Aging, Alzheimer Disease, Protection Against

    The Revitalize Study in Older Adults at Risk for Alzheimer's Disease

    • Completed
    • Age: 65 to 89 years
    • Phase 2
    • Medical device
    • Results posted

    The goal of this multi-site double blinded randomized sham-controlled Phase II clinical trial is to test a novel, relatively low cost, low risk, and potentially high impact therapeutic intervention in older adults who are at…

    Trial name
    NCT04018092
    Testing
    Active NIR-PBM
    Where
    2 sites in United States
    Volunteers
    168 people, healthy volunteers welcome
    Sponsor
    University of Florida
    Can I take part? NCT04018092
  • Insufficient Lactation

    Improving Lactation Success in Black Mothers of Critically Ill Infants

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    Racial disparities result in Black infants in the neonatal intensive care unit (NICU) receiving less breast milk (BM) than White and Hispanic infants.1 BM improves infant health yet mothers of critically ill infants produce…

    Trial name
    NCT05147987
    Testing
    Hands free wearable breast pump
    Where
    United States
    Volunteers
    32 people, healthy volunteers welcome
    Sponsor
    University of Florida
  • Essential Tremor, Parkinson Disease

    Physiology, Imaging and Modeling of Essential Tremor

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    This project aims to investigate novel ways to deliver brain stimulation to Essential Tremor (ET) patients by introducing software changes to their existing devices.

    Conditions
    Essential Tremor, Parkinson Disease, Dystonia
    Trial name
    NCT03811405
    Testing
    Active biphasic pulse stimulation---Home Settings, Active biphasic pulse stimulation---VIN Biphasic, Active biphasic pulse stimulation---Stimulator Off
    Where
    2 sites in United States
    Volunteers
    12 people
    Sponsor
    University of Florida
  • Medulloblastoma, Neuroectodermal Tumor

    Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

    • Completed
    • Age: Up to 30 years
    • Phase 2
    • Injection or infusion
    • Results posted

    Immunotherapy is a specific approach to treating cancer that has shown promise in adult patients for the treatment of melanoma, malignant brain tumors, and other cancers.

    Trial name
    Re-MATCH (NCT01326104)
    Testing
    TTRNA-xALT, TTRNA-DCs
    Where
    3 sites in United States
    Volunteers
    26 people
    Sponsor
    University of Florida
    Can I take part? Re-MATCH
  • HPV

    Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness

    • Completed
    • Age: 10 years and older
    • Vaccines
    • Lifestyle or therapy programme
    • Results posted

    This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living in Florida.

    Trial name
    Text&Talk (NCT05006833)
    Testing
    Brief Provider Training - Bundled Approach, Brief Provider Training - Benefits Approach, Parent Interactive Text Message - Bundled Approach
    Where
    United States
    Volunteers
    8,043 people, healthy volunteers welcome
    Sponsor
    University of Florida
    Can I take part? Text&Talk

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in